(Q57154790)

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Monocyte derived interleukin (IL)-23 is an important determinant of synovial IL-17A expression in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Alleles of the IL12B 3'UTR associate with late onset of type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Polymorphisms of the IL12B and IL23R genes are associated with psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

IL23R: a susceptibility locus for celiac disease and multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: evidence of a general susceptibility locus

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

The dual nature of TH17 cells: shifting the focus to function

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells: a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: Rationale for combination treatment during arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

IL-22 and inflammation: leukin' through a glass onion

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

The clinical role of IL-23p19 in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Increased Interleukin 21 (IL-21) and IL-23 Are Associated with Increased Disease Activity and with Radiographic Status in Patients with Early Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

IL-21 regulates Th17 cells in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2011.80

7 January 2021